Trial intelligence / Profile preview

Rectal diclofenac versus EMLA versus placebo for pain control during hysterosalpingography

PACTR201904530885595Completed

Sponsor
National Hospital Abuja
Start
Oct 2018
Modality
Small Molecules, Drug Delivery Systems
Countries
1
01

Overview

Randomised trial comparing Rectal diclofenac, EMLA cream and Placebo (3 arms). Primary endpoint: Mean pain score during hysterosalpingography. Started Oct 2018; status: completed.

02

Drugs

diclofenaclidocaine + prilocaine

Beyond the preview

Go deeper on PACTR201904530885595.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201904530885595.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call